Clinical trial · Interventional
Lifei Xiaoji Wan Treatment's of Early-stage NSCLC and Its Impact on the Tumor Microenvironment
Study on the Therapeutic Effect of Lifei Xiaoji Wan on Lung Adenocarcinoma in the Early Stage of Ground Glass Nodule (Ia Stage) and Its Effect on Tumor Microenvironment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluated the relationship between the clinical efficacy, histopathological changes and tumor microenvironment of the pharmacopharmacologic Lifei Xiaoji Wan in the treatment of early stage lung adenocarcinoma, and improved high-level clinical evidence and action targets for the prevention and treatment of early stage lung cancer by traditional Chinese medicine
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early Stage Lung Adenocarcinoma | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Conventional treatment with Western medicine | Drug | — | UNRESOLVED |
| Lifei Xiaoji Wan | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- trial group
- description
- The patients in the trial group received routine Western medicine treatments, and oral Lifei Xiaoji Wan (10 pills/time,3 times/day).
- interventionNames
- Drug: Lifei Xiaoji Wan
- type
- PLACEBO_COMPARATOR
- label
- control group
- description
- The patients in the control group received routine Western medicine treatments.
- interventionNames
- Drug: Conventional treatment with Western medicine
Primary outcomes (3)
- measure
- Lung Cancer Quality of Life Scale (FACT-L)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * It met the diagnostic criteria of non-small cell lung cancer and was confirmed by pathology, cytology and other relevant examinations. * Preoperative thin-slice CT showed pure ground glass pulmonary nodules with a size of 10mm-30mm. Intraoperative and postoperative pathology indicated adenocarcinoma, and the tumor stage (TNM) was stage Ia. * Age: 18-75 years old * Expected survival \>5 years * Informed consent and sign informed consent Exclusion Criteria: * Patients who have undergone surgery * Patients with serious dysfunction of heart, liver, lung, kidney and other important organs * Patients with mental illness who were unable to complete the study
References
Publications (0)
Data not yet available